IT - INET Nordic and Genium INET – Implementation of T+2

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
IT - INET Nordic and Genium INET – Implementation of T+2 – information on testing (41/14)

This is a joint notice regarding testing of T+2 standard settlement in cash equities, fixed income instruments and derivatives traded on NASDAQ OMX Nordic, NASDAQ OMX Baltic and NASDAQ OMX Derivatives Markets.

As of October 6, 2014, NASDAQ OMX Copenhagen, Helsinki, Stockholm, Iceland (pending results of the ongoing consultation), Tallinn, Riga and Vilnius exchanges and the existing First North markets will adopt T+2 standard settlement to securities admitted to trading on these venues.

In addition to securities, NASDAQ OMX Derivatives Markets will also adopt the T+2 settlement to physical deliveries resulting from expiries of derivatives with equities and the Danish fixed income as an underlying instrument.  The Swedish fixed income derivatives remain in T+3 settlement on expiry. This is done in agreement with the participants of the NASDAQ OMX Derivatives Markets.

The implementation of T+2 standard settlement is a parameter change in existing functionality in INET Nordic and Genium INET systems. In order to facilitate members’ own system testing and verification, INET Nordic and Genium INET test systems are available for T+2 testing according to the information below. Testing is voluntary but recommended.

Testing time schedule

T+2 standard settlement on all the above instruments will be available for testing in two phases:

  • Phase 1 for early testing: June 16 – June 27, 2014
  • Phase 2 for testing: August 18 – October 3, 2014

During the period from June 30 to August 15, 2014, current T+3 standard settlement is rolled back to test systems.

Test systems available

  • INET OTF
  • Genium INET External Test 1 & External Test 3
  • GCF3 and GCF4

Implementation details

  • Genium Consolidated Feed TIP specifications: description for SettlementDate field in real-time Trade (TRd) message will be changed to “If the settlement date is not disseminated, the default date is two days from the trade date.”
  • No other impact on any protocols used by the INET Nordic, Genium INET and the NASDAQ OMX surrounding systems.

Changes to reference data via Genium Consolidated Feed TIP

  • Instruments traded in INET Nordic: not applicable (GCF TIP does not distribute the number of settlement days for these instruments).
  • Fixed income instruments traded in Genium INET: Number of settlement days is disseminated in NoOfSettlementDays field in BasicDataTradable (BDt) message.
  • Equity derivatives traded in Genium INET: not applicable (GCF TIP does not distribute the number of settlement days on expiration).

End-to-end testing

  • For end-to-end testing including settlement, members are advised to make necessary arrangements themselves with the cash CCP (when applicable) and with relevant the CSD(s).

For more information, please visit NASDAQ OMX website for Q&A – Implementation of T+2 . The purpose of the Q&A is to provide answers to the most common questions regarding the impact of the transition to T+2 standard settlement. The Q&A is a living document and will be updated when new information is available.

Support

If you have any questions regarding this Exchange Notice, please contact

Best regards,

NASDAQ OMX Nordic, NASDAQ OMX Baltic and NASDAQ OMX Derivatives Markets

NASDAQ OMX Nordic is not a legal entity but describes the common offering from the NASDAQ OMX exchanges in Helsinki, Copenhagen, Stockholm and Iceland.

NASDAQ OMX Baltic is not a legal entity but describes the common offering from the NASDAQ OMX exchanges in Tallinn, Riga and Vilnius .

NASDAQ OMX Derivatives Markets is a secondary name to NASDAQ OMX Stockholm, used for the derivatives trading and clearing operations.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Gildan's Crisis: Investors Face Losses Amid Lawsuit

Updated Category News Views 245

Gildan Investors, Brace Yourself Poor old Gildan Activewear finds itself in hot water again, with a class action lawsuit cropping up like an unexpected storm on farmers' day. Any traders remotely involved with NYSE:GIL should pay damn close attention, because with a December 14, 2026 deadline looming, it's crunch time. The Root of the Lawsuit The plot thickens here,...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 146

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 60

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
Strathcona and Greenfire Set Sights on Major Merger

Updated Category News Views 68

Strathcona's Bold Move for Greenfire: A Game Changer? Just this week, Strathcona Resources Ltd. decided to make a big splash in the oil sands space by proposing to acquire Greenfire Resources Ltd. This isn’t your run-of-the-mill grab—it's a strategic tango expected to shift billions and reshape what we know about Canada’s oil sands territory. Unpicking the Deal...

Continue Reading
Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 272

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 354

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 414

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Intelligent Communication Forum Eyes Global Ecosystem Shift

Updated Category News Views 646

China's Grand Vision for Intelligent Communication You know what they say about big ideas—they start in the most bustling of places. And here we are in Wuxi, a city's pulse pounding with ambition, hosting the 2026 China International Intelligent Communication Forum. Picture it: From November 8th to 10th, movers, shakers, and visionaries are scribbling new blueprints for...

Continue Reading
Cars.com Inducement Awards: New CPO Earns Stock Boost

Updated Category News Views 22

Revving Up With Incentives: A Strategic Move by Cars.com Ever seen a stock maneuver that feels more like a chess play than a plain deal? On November 5, 2026, Cars.com (NYSE: CARS) fired up quite a strategic engine. They handed out a heap of restricted stock units—373,345 to be precise—to Mausam Bhatt, freshly minted as their Chief Product Officer. This isn't just your...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 586

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading

Top 5 Most Recently Viewed Articles

Spring Health Launches Initiative for Mental Health Relief

Updated Category News Views 472

Spring Health's Commitment to Mental Health Support In response to the recent devastation from the wildfires, Spring Health has announced a significant initiative aimed at providing mental health resources to those in distress. The company has committed $500,000 to launch a new Wildfire Mental Health Support Program aimed at individuals and families impacted by these...

Continue Reading
Serina Therapeutics Showcases Innovations at Global Conference

Updated Category News Views 263

Serina Therapeutics Takes the Stage at Major Investment Event Serina Therapeutics, Inc., also known as Serina (NYSE American: SER), is set to make an impactful presentation at the H.C. Wainwright 27th Annual Global Investment Conference. This prestigious event unfolds in New York City, where Steve Ledger, the Chief Executive Officer of Serina, will take the spotlight at...

Continue Reading
Patrick Industries Faces Scrutiny Amid Merger Plans

Updated Category News Views 48

Cracks in the Merger Deal? Nobody likes it when a seemingly routine merger suddenly faces the magnifying glass of a class action attorney. But that's where we are with Patrick Industries (NASDAQ: PATK), folks. Juan Monteverde, the big hitter from Monteverde & Associates, is eyeing this one closely. This New York-based firm, perched in the legendary Empire State Building...

Continue Reading
Revolutionary Arab Human Pangenome: Advancing Genomic Equity

Updated Category News Views 124

Groundbreaking Achievement in Genomics PacBio, a renowned leader in sequencing technology, has made a substantial contribution to global genomics with the announcement of the first Arab human pangenome. This historic achievement is powered by their innovative HiFi long-read sequencing technology, showcasing the potential of genomic science to progress health equality...

Continue Reading
RCI Hospitality Secures Significant Legal Representation Ahead of Deadline

Updated Category News Views 226

Introduction to RCI Hospitality Holdings, Inc. RCI Hospitality Holdings, Inc. (NASDAQ: RICK) is known for its diverse portfolio in the hospitality sector. With establishments across the country, RCI focuses on providing entertainment and dining experiences through various brands. As an investor in RCI Hospitality, it’s essential to stay informed about recent legal...

Continue Reading